Monday , December 17 2018
Breaking News
Home / BUSINESS / Lupin launches generic Potassium Chloride Oral Solution

Lupin launches generic Potassium Chloride Oral Solution

Lupin has launched Potassium Chloride Oral Solution USP, 20 mEq/15mL (10%) and 40 mEq/15 mL (20%), having received an approval from the United States Food and Drug Administration (USFDA) earlier.

The company’s Potassium Chloride Oral Solution USP, 20 mEq/15mL (10%) and 40 mEq/15 mL (20%), is the generic equivalent of Genus Lifesciences, Inc.’s Potassium Chloride Oral Solution. It is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods and/or diuretic dose reduction are insufficient.

Potassium Chloride Oral Solution USP, 20 mEq/15mL (10%) and 40 mEq/15 mL (20%), had annual sales of approximately $184.95 million in the US (IQVIA MAT June 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Loading...

Leave a Reply

Your email address will not be published. Required fields are marked *

*